Thomas A. Grugle, M.D., Principal Investigator

Form 483

Dallas, Texas, United StatesFEI 3009106065Issued September 20, 2011

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3009106065.

Observations1

Issue DateSeptember 20, 2011

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Thomas A. Grugle, M.D., Principal Investigator
Location: Dallas, Texas, United States
FEI Number: 3009106065
Product Type: Drugs
Issue Date: September 20, 2011
Country: United States

Inspection History, 2011 to 2015

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Thomas A. Grugle, M.D., Principal Investigator FDA Form 483, Dallas, Texas, September 20, 2011